Systemic chemotherapy for patients with bladder cancer - current controversies and future directions

Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840, Hall, G. D., Forster, M. and Protheroe, A. S. 2004. Systemic chemotherapy for patients with bladder cancer - current controversies and future directions. Cancer Treatment Reviews 30 (4) , pp. 343-358. 10.1016/j.ctrv.2003.12.005

Full text not available from this repository.

Abstract

Many localised, superficial bladder cancers can be effectively controlled. However, disease which has spread to nodes outside the pelvis or to distant organs is generally incurable and systemic therapies, rather than surgery, are appropriate. Combination chemotherapy based around established cytotoxic drugs such as cisplatin has proven benefit in palliating symptoms and prolonging survival in responsive patients with advanced disease. Combination chemotherapies which include newer cytotoxic drugs such as gemcitabine provide the potential for equivalent efficacy with less toxicity than established regimens. Between the extremes of superficial and advanced disease, muscle-invasive bladder cancers have traditionally been treated, with curative intent, by radical surgery or radiotherapy. However, newly published data suggest, for the first time, genuine survival benefits from peri-operative chemotherapy. This article reviews the evidence for cisplatin-based chemotherapy in advanced disease, assesses the potential benefits of newer cytotoxic drugs, discusses the latest evidence pertaining to peri-operative chemotherapy in muscle-invasive disease, and looks forward to potential new biological agents in the systemic therapy of bladder cancer.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	Q Science > QH Natural history > QH426 Genetics R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Uncontrolled Keywords:	Bladder cancer, Chemotherapy, Cisplatin, Gemcitabine, Biological therapy, Gene therapy
Publisher:	Elsevier
ISSN:	0305-7372
Last Modified:	19 Oct 2022 08:43
URI:	https://orca.cardiff.ac.uk/id/eprint/18826

Citation Data

Cited 36 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item